Naprorex (Naproxen)

Naproxen, the active ingredient in Naprorex, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It provides pain relief, reduces inflammation and lowers fever in adult patients with musculoskeletal and other acute conditions, and is approved in the European Union for osteoarthritis, rheumatoid arthritis and dysmenorrhea.

GNH USA supplies Naprorex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.

Naproxen is an NSAID that acts on inflammatory pathways to alleviate several painful and inflammatory conditions.

Osteoarthritis: reduces joint pain and improves mobility Rheumatoid arthritis: diminishes inflammation and stiffness Dysmenorrhea: alleviates menstrual cramps Acute musculoskeletal pain: provides rapid pain relief Fever: lowers elevated body temperature

Naproxen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset (indigestion, heartburn) - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Renal impairment or failure - Hepatic injury - Cardiovascular thrombotic events (e.g., myocardial infarction, stroke) - Severe skin reactions such as Stevens‑Johnson syndrome - Anaphylaxis or severe allergic reactions

When prescribing or dispensing Naprorex, consider the following safety measures.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding Monitor renal function: especially in patients with dehydration or pre‑existing kidney disease Check cardiovascular status: use cautiously in patients with heart disease or hypertension Avoid use in late pregnancy: contraindicated in the third trimester Review concomitant medications: consider interactions with other NSAIDs, anticoagulants or SSRIs Store at ambient temperature: keep below 25 °C in the original pack, protect from moisture

Naproxen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk - Selective COX‑2 inhibitors: additive gastrointestinal toxicity - High‑dose aspirin: enhanced renal toxicity - Methotrexate: decreased clearance leading to toxicity - Lithium: increased serum levels

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function - Diuretics: risk of electrolyte imbalance - SSRIs or SNRIs: heightened bleeding risk - Corticosteroids: increased ulcer risk